SCHEMBL4122873

SCHEMBL4122873

O=C(C#Cc1cccc(Cl)c1)N1CCc2ccccc2CC1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 1/20 0.50
CASP3 P42574 1/20 0.50
RAB9A P51151 1/20 0.50
SENP8 Q96LD8 1/20 0.50
SENP7 Q9BQF6 1/20 0.50
SENP6 Q9GZR1 1/20 0.50
ENPP2 Q13822 1/20 0.49
ATXN2 Q99700 1/20 0.49
GRM5 P41594 9/20 0.47
CYP3A4 P08684 1/20 0.47
MEN1 O00255 4/20 0.46
KMT2A Q03164 4/20 0.46
PDE4B Q07343 1/20 0.45
TAS1R3 Q7RTX0 1/20 0.43
TAS1R1 Q7RTX1 1/20 0.43
TAS1R2 Q8TE23 1/20 0.43
LMNA P02545 1/20 0.43
AR P10275 1/20 0.43
SPR P35270 1/20 0.41
USP2 O75604 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4111987 0.94 NPC1 (0.56) NPC1CASP3RAB9ASENP8SENP7
SCHEMBL4106224 0.86 NPC1 (0.48) NPC1CASP3RAB9ASENP8SENP7
SCHEMBL4118264 0.85 ESR2 (0.49) NPC1CASP3RAB9ASENP8SENP7
SCHEMBL4112825 0.85 GRM5 (0.47) NPC1CASP3RAB9ASENP8SENP7
SCHEMBL4111107 0.84 ERCC1 (0.49) NPC1CASP3RAB9ASENP8SENP7
SCHEMBL4124858 0.83 GRM5 (0.46) NPC1CASP3RAB9ASENP8SENP7
SCHEMBL4113932 0.82 GRM5 (0.47) NPC1CASP3RAB9ASENP8SENP7
SCHEMBL4113280 0.81 GRM5 (0.44) NPC1CASP3RAB9ASENP8SENP7
SCHEMBL4118618 0.81 DRD1 (0.53) NPC1CASP3RAB9ASENP8SENP7
SCHEMBL4117529 0.81 PDE4B (0.55) NPC1MEN1KMT2APDE4BALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090075978-A1 SUBSTITUTED PROPIOLIC ACID AMIDES AND THEIR USE FOR PRODUCING DRUGS GRUNENTHAL GMBH (DE) 2009-03-19 US claimed
US-20090075978-A1 SUBSTITUTED PROPIOLIC ACID AMIDES AND THEIR USE FOR PRODUCING DRUGS GRUNENTHAL GMBH (DE) 2009-03-19 US disclosed
US-20090075978-A1 SUBSTITUTED PROPIOLIC ACID AMIDES AND THEIR USE FOR PRODUCING DRUGS GRUNENTHAL GMBH (DE) 2009-03-19 US disclosed
EP-1968938-A1 SUBSTITUTED PROPIOLIC ACID AMIDES AND THEIR USE FOR PRODUCING DRUGS Grünenthal GmbH (DE) 2008-09-17 EP disclosed
WO-2007079957-A1 SUBSTITUTED PROPIOLIC ACID AMIDES AND THEIR USE FOR PRODUCING DRUGS Grünenthal GmbH (DE) 2007-07-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090075978-A1 SUBSTITUTED PROPIOLIC ACID AMIDES AND THEIR USE FOR PRODUCING DRUGS PCCA, PPARA, PTGES NPC1 2295/4885CASP3 1769/4885RAB9A 4520/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.